Safety Reporting Requirements Human Drug/Biological Products | Federal Regulations · Congress.wiki

Rulemaking

FDA

RIN 0910-AA97

FDA-2000-N-0108

Safety Reporting Requirements Human Drug/Biological Products

Documents

Comments

Description

Status: OPEN

Comment Period OpensMar 18, 2003

Comment Period ClosesOct 15, 2003

Type	Title	Posted	Comments	Status
Final Rule	Final Rule re Investigational New Drug Safety Reporting Requirements for Human Drug and Biological Products: Safety Reporting Requirements for Bioavailability and Bioequivalence Studies in Humans FR Doc: 2010-24296	Sep 29, 2010

Total Comments

POSTMARKETING

SADR

PRESCRIPTION DRUGS

BIOLOGICAL PRODUCTS

HUMAN DRUG

SAFETY REPORTING

CBER